Search

Search Constraints

You searched for: Author/Creator Tsakmaklis, Nickolas

Search Results

1. CXCR4 WHIM‐like frameshift and nonsense mutations promote ibrutinib resistance but do not supplant MYD88L265P‐directed survival signalling in Waldenström macroglobulinaemia cells. (5th November 2014)

2. Genomic evolution of ibrutinib‐resistant clones in Waldenström macroglobulinaemia. (27th February 2020)

3. Partial response or better at six months is prognostic of superior progression‐free survival in Waldenström macroglobulinaemia patients treated with ibrutinib. (18th November 2020)

4. The BCL2 antagonist ABT‐199 triggers apoptosis, and augments ibrutinib and idelalisib mediated cytotoxicity in CXCR4Wild‐type and CXCR4WHIM mutated Waldenstrom macroglobulinaemia cells. (12th January 2015)